RESMED INC·4

Nov 18, 8:38 PM ET

Leong Justin 4

4 · RESMED INC · Filed Nov 18, 2022

Insider Transaction Report

Form 4
Period: 2022-11-16
Leong Justin
Chief Product Officer
Transactions
  • Award

    ResMed Common Stock Options

    2022-11-16$224.58/sh+9,973$2,239,7369,973 total
    Exercise: $224.58From: 2023-11-11Exp: 2029-11-16ResMed Common Stock (9,973 underlying)
Holdings
  • ReMed Common Stock

    48,594
Footnotes (1)
  • [F1]Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2023, 2024 and 2025.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT